- Home
- PRSO vs RSLS Comparison
PRSO vs RSLS Comparison
Compare PRSO & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- RSLS
- Stock Information
- Founded
- PRSO 2008
- RSLS 2002
- Country
- PRSO United States
- RSLS United States
- Employees
- PRSO N/A
- RSLS N/A
- Industry
- PRSO Semiconductors
- RSLS Medical/Dental Instruments
- Sector
- PRSO Technology
- RSLS Health Care
- Exchange
- PRSO Nasdaq
- RSLS Nasdaq
- Market Cap
- PRSO 3.3M
- RSLS 3.2M
- IPO Year
- PRSO 2001
- RSLS 2007
- Fundamental
- Price
- PRSO $0.70
- RSLS $0.31
- Analyst Decision
- PRSO Strong Buy
- RSLS Hold
- Analyst Count
- PRSO 2
- RSLS 1
- Target Price
- PRSO $3.38
- RSLS N/A
- AVG Volume (30 Days)
- PRSO 74.6K
- RSLS 36.0M
- Earning Date
- PRSO 05-12-2025
- RSLS 04-04-2025
- Dividend Yield
- PRSO N/A
- RSLS N/A
- EPS Growth
- PRSO N/A
- RSLS N/A
- EPS
- PRSO N/A
- RSLS N/A
- Revenue
- PRSO $14,573,000.00
- RSLS $8,006,000.00
- Revenue This Year
- PRSO $3.74
- RSLS $52.80
- Revenue Next Year
- PRSO $37.09
- RSLS N/A
- P/E Ratio
- PRSO N/A
- RSLS N/A
- Revenue Growth
- PRSO 5.99
- RSLS N/A
- 52 Week Low
- PRSO $0.52
- RSLS $0.30
- 52 Week High
- PRSO $2.34
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- PRSO 49.46
- RSLS 40.15
- Support Level
- PRSO $0.59
- RSLS $0.30
- Resistance Level
- PRSO $0.69
- RSLS $0.70
- Average True Range (ATR)
- PRSO 0.07
- RSLS 0.28
- MACD
- PRSO 0.01
- RSLS 0.04
- Stochastic Oscillator
- PRSO 75.00
- RSLS 0.36
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.